Carl-Wilhelm Vogel, MD, PhD Director

Carl-Wilhelm Vogel, MD, PhD Director

Financial Conflict of Interest Disclosure Incode Biopharmaceutics, Inc.

Hawaii State Support State Cigarette Tax Increase (Act 316, July 2006): - increases the cigarette tax in six annual steps by 1 cent/cigarette or 20 cents/pack (from $1.40/pack to eventually $2.60/pack) - earmarks tax revenue for four health care entities - CRCH receives 2 cents/cigarette or 40 cents per pack - no sunset date

Hawaii State Support Supporters of Act 316: Department of Health American Cancer Society American Heart Association American Lung Association Hawaii Medical Association Hawaii Dental Association Hawaii Nursing Association Hawaii Public Health Organization Oncology Nursing Society Hawaii Science and Technology Council Hawaii Society for Clinical Oncology Local Hospitals Local Oncologists

Hawaii State Support Opponents of Act 316: Tobacco Industry One Local Hospital

Hawaii State Support Cigarette Tax Increase Concerns: - Tax Increase - Illegal Cigarette Sales

Hawaii State Support Cigarette Tax Revenue: 1 cent/cigarette raises $900,000/month or over $10 million/year

Hawaii State Support Cigarette Tax Allowed Expenditures: Research, Operation, and Capital Expenditures of the Cancer Research Center of Hawaii

Cancer Center in Kakaako

Hawaii State Support Opponents of Act 316: Tobacco Industry One Local Hospital

Carl-Wilhelm Vogel, MD, PhD Director

Carl-Wilhelm Vogel, MD, PhD Director

Carl-Wilhelm Vogel, MD, PhD Director

Presentation Transcript

David C. Deitz, MD, PhD National Medical Director

Michael G. Kahn MD, PhD Biomedical Informatics Core Director

François Schiele , MD, PhD, Nicolas Meneveau , MD, PhD,

Carlos F. Cáceres, MD, PhD Professor and Director

Kevin Fenton, MD, PhD, FFPH Director

Marc Bulterys, MD PhD Director, Global AIDS Program, China

Emmanouil S. Brilakis , MD, PhD Director, Cardiac Catheterization Laboratory

Kevin Fenton, MD, PhD, FFPH Director

Kevin A. Fenton , MD, PhD, FFPH Director

Introducing the Professional Development Office Donna L. Vogel, MD, PhD

Laurence de Leval, MD, PhD,* David Waltregny, MD, PhD,w Jacques Boniver, MD, PhD,*

Alireza Atri, MD, PhD Associate Director, Clinical Programs,

William Pao, MD, PhD Assistant Director, Personalized Cancer Medicine

Anthony Hayward, MD PhD Director, Division for Clinical Research,

Szabolcs Péter , MD, PhD Peter Weber, MD, PhD

Kensaku Kawamoto, MD, PhD Director, Knowledge Management and Mobilization

Elisabeth Dykens, PhD — Director Louis Muglia, MD — Associate Director